300026 红日药业
已收盘 12-24 15:00:00
资讯
新帖
简况
《股市简讯》中国红日药业跌4%,第二大股东拟减持股份
路透中文 · 14:57
《股市简讯》中国红日药业跌4%,第二大股东拟减持股份
红日药业(300026.SZ)股东姚小青拟减持不超2.56%股份
智通财经 · 12-23 20:27
红日药业(300026.SZ)股东姚小青拟减持不超2.56%股份
红日药业最新公告:股东拟减持不超过2.56%公司股份
证券之星 · 12-23 20:19
红日药业最新公告:股东拟减持不超过2.56%公司股份
12月17日红日药业现929.9万元大宗交易
证券之星 · 12-17
12月17日红日药业现929.9万元大宗交易
红日药业12月13日现1笔大宗交易 成交金额994.46万元
新浪证券-红岸工作室 · 12-13
红日药业12月13日现1笔大宗交易 成交金额994.46万元
12月13日红日药业现1笔折价17.66%的大宗交易 合计成交994.46万元
证券之星 · 12-13
12月13日红日药业现1笔折价17.66%的大宗交易 合计成交994.46万元
红日药业最新公告:公司伊班膦酸钠注射液通过仿制药一致性评价
证券之星 · 12-12
红日药业最新公告:公司伊班膦酸钠注射液通过仿制药一致性评价
红日药业(300026.SZ)伊班膦酸钠注射液通过仿制药一致性评价
智通财经 · 12-12
红日药业(300026.SZ)伊班膦酸钠注射液通过仿制药一致性评价
红日药业(300026.SZ):酮咯酸氨丁三醇注射液通过仿制药一致性评价
智通财经 · 11-27
红日药业(300026.SZ):酮咯酸氨丁三醇注射液通过仿制药一致性评价
红日药业最新公告:公司酮咯酸氨丁三醇注射液通过仿制药一致性评价
证券之星 · 11-27
红日药业最新公告:公司酮咯酸氨丁三醇注射液通过仿制药一致性评价
A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。
美港电讯 · 11-26
A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。
红日药业11月21日现3笔大宗交易 成交金额4596.21万元
新浪证券-红岸工作室 · 11-21
红日药业11月21日现3笔大宗交易 成交金额4596.21万元
11月21日红日药业现3笔折价19.42%的大宗交易 合计成交4596.21万元
证券之星 · 11-21
11月21日红日药业现3笔折价19.42%的大宗交易 合计成交4596.21万元
10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元
证券之星 · 10-25
10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元
红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%
智通财经 · 10-24
红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%
红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%
证券之星 · 10-24
红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%
10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股
证券之星 · 10-08
10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股
红日药业:目前公司与您提到的公司暂无合作
证券之星 · 09-12
红日药业:目前公司与您提到的公司暂无合作
红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药
证券之星 · 09-10
红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药
红日药业新注册《网采对接管理平台V1.0》项目的软件著作权
证券之星 · 09-10
红日药业新注册《网采对接管理平台V1.0》项目的软件著作权
加载更多
公司概况
公司名称:
天津红日药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-10-30
主营业务:
天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。
发行价格:
60.00
{"stockData":{"symbol":"300026","market":"SZ","secType":"STK","nameCN":"红日药业","latestPrice":3.86,"timestamp":1735023789000,"preClose":3.98,"halted":0,"volume":77527305,"delay":0,"floatShares":2686000000,"shares":3004000000,"eps":0.0552,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.12,"latestTime":"12-24 15:00:00","open":3.9,"high":3.95,"low":3.82,"amount":300000000,"amplitude":0.0327,"askPrice":3.87,"askSize":4070,"bidPrice":3.86,"bidSize":8519,"shortable":0,"etf":0,"ttmEps":0.0552,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735090200000},"adr":0,"adjPreClose":3.98,"symbolType":"stock","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":4.38,"lowLimit":3.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":3004154837,"pbRate":1.36,"roa":"--","roe":"1.92%","epsLYR":0.17,"committee":0.322216,"marketValue":11596000000,"floatMarketCap":10367000000,"peRate":69.927537,"changeRate":-0.0302,"turnoverRate":0.0289,"status":1},"requestUrl":"/m/hq/s/300026","defaultTab":"news","newsList":[{"id":"2493773263","title":"《股市简讯》中国红日药业跌4%,第二大股东拟减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493773263","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493773263?lang=zh_cn&edition=full","pubTime":"2024-12-24 14:57","pubTimestamp":1735023474,"startTime":"0","endTime":"0","summary":"《股市简讯》中国红日药业跌4%,第二大股东拟减持股份* 中国红日药业300026.SZ周二午盘跌幅扩大至4%。* 该公司此前公告称,第二大股东姚小青拟减持不超过76,869,432股,占本公司总股本比例2.5588%。* 红日药业今年迄今跌9.2%,同期沪深300指数.CSI300大幅上扬16%。* 中证医药100指数.CSI000978盘中一度升1.1%。(完)更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文;审校 吴云凌) ((kaiwen.xu@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nL4T3NP0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0239","300026","BK0077"],"gpt_icon":0},{"id":"2493675154","title":"红日药业(300026.SZ)股东姚小青拟减持不超2.56%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493675154","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493675154?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:27","pubTimestamp":1734956829,"startTime":"0","endTime":"0","summary":"通财经APP讯,红日药业(300026.SZ)公告,公司股东姚小青计划自本公告披露之日起十五个交易日后的三个月内以集中竞价或大宗交易方式减持公司股份不超过7686.94万股(占公司总股本比例2.56%)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0077","300026","BK0188"],"gpt_icon":0},{"id":"2493511257","title":"红日药业最新公告:股东拟减持不超过2.56%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493511257","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493511257?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:19","pubTimestamp":1734956391,"startTime":"0","endTime":"0","summary":"红日药业公告,公司持股5%以上的股东姚小青计划自公告披露之日起十五个交易日后的三个月内,以集中竞价或大宗交易方式减持公司股份不超过7686.94万股,占公司总股本比例2.5588%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300031289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","300026","BK0077"],"gpt_icon":0},{"id":"2492933034","title":"12月17日红日药业现929.9万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2492933034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492933034?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:07","pubTimestamp":1734426471,"startTime":"0","endTime":"0","summary":"证券之星消息,12月17日红日药业发生大宗交易,交易数据如下:大宗交易成交价格3.92元,相对当日收盘价折价6.44%,成交237.22万股,成交金额929.9万元,买方营业部为中信证券股份有限公司北京呼家楼证券营业部,卖方营业部为华泰证券股份有限公司安徽分公司。近三个月该股共发生11笔大宗交易,合计成交43.01万手,折价成交11笔。截至2024年12月17日收盘,红日药业报收于4.19元,下跌0.95%,换手率3.7%,成交量99.48万手,成交额4.21亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700028491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"2491349001","title":"红日药业12月13日现1笔大宗交易 成交金额994.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491349001","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491349001?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:00","pubTimestamp":1734080400,"startTime":"0","endTime":"0","summary":" 12月13日,红日药业收跌2.56%,收盘价为4.19元,发生1笔大宗交易,合计成交量288.25万股,成交金额994.46万元。 第1笔成交价格为3.45元,成交288.25万股,成交金额994.46万元,溢价率为-17.66%,买方营业部为山西证券股份有限公司太原平阳路证券营业部,卖方营业部为平安证券股份有限公司深圳金田路证券营业部。 进一步统计,近3个月内该股累计发生10笔大宗交易,合计成交金额为1.35亿元。该股近5个交易日累计下跌0.95%,主力资金合计净流出6515.43万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-13/doc-incziefr2753390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0188","300026","BK0077"],"gpt_icon":0},{"id":"2491346810","title":"12月13日红日药业现1笔折价17.66%的大宗交易 合计成交994.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491346810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491346810?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:51","pubTimestamp":1734079870,"startTime":"0","endTime":"0","summary":"证券之星消息,12月13日红日药业发生大宗交易,交易数据如下:大宗交易成交价格3.45元,相对当日收盘价折价17.66%,成交288.25万股,成交金额994.46万元,买方营业部为山西证券股份有限公司太原平阳路证券营业部,卖方营业部为平安证券股份有限公司深圳金田路证券营业部。近三个月该股共发生10笔大宗交易,合计成交40.63万手,折价成交10笔。截至2024年12月13日收盘,红日药业报收于4.19元,下跌2.56%,换手率3.18%,成交量85.37万手,成交额3.61亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300029050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300026","BK0188"],"gpt_icon":0},{"id":"2490874802","title":"红日药业最新公告:公司伊班膦酸钠注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2490874802","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490874802?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:47","pubTimestamp":1733993251,"startTime":"0","endTime":"0","summary":"红日药业公告称,公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,伊班膦酸钠注射液通过仿制药质量和疗效一致性评价,并同意批准本品增加2ml:2mg规格的补充申请,核发药品批准文号。伊班膦酸钠注射液系第三代双膦酸盐类药物,主要治疗绝经后骨质疏松症、预防乳腺癌骨转移患者骨相关事件的发生、治疗伴有或不伴有骨转移的恶性肿瘤引起的高钙血症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200026591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300026","BK0077","BK0188"],"gpt_icon":0},{"id":"2490879198","title":"红日药业(300026.SZ)伊班膦酸钠注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879198","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879198?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:21","pubTimestamp":1733991662,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业 公告,近日,公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,药品名称为伊班膦酸钠注射液,伊班膦酸钠注射液,经审查,本品通过仿制药质量和疗效一致性评价,并同意批准本品增加 2ml: 2mg 规格的补充申请,核发药品批准文号。据悉,伊班膦酸钠注射液系第三代双膦酸盐类药物,由瑞士罗氏制药公司研发,于1996年在德国首次上市,商品名为Bondronat。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0239","300026","BK0188"],"gpt_icon":0},{"id":"2486784598","title":"红日药业(300026.SZ):酮咯酸氨丁三醇注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2486784598","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486784598?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:51","pubTimestamp":1732701095,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)公告,公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,酮咯酸氨丁三醇注射液通过仿制药一致性评价。酮咯酸氨丁三醇注射液是一种止痛药物。可以静脉注射,也可以肌肉注射。通常在术后短时间镇痛使用,镇痛效果比较强烈,可以达到阿片类(如吗啡)镇痛药的短期镇痛效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300026","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2486845845","title":"红日药业最新公告:公司酮咯酸氨丁三醇注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2486845845","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486845845?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:31","pubTimestamp":1732699882,"startTime":"0","endTime":"0","summary":"红日药业公告,公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,公司产品酮咯酸氨丁三醇注射液通过仿制药质量和疗效一致性评价。该药品是一种止痛药物,通常在术后短时间镇痛使用。通过一致性评价是国家药品监管部门对公司研发、生产综合能力和产品质量的认可,对公司研发能力的提升具有积极意义。但药品投产后的未来市场销售情况可能受到市场环境变化、药品集中带量采购政策等因素影响,存在不确定性。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700030608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"2486912013","title":"A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2486912013","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486912013?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:10","pubTimestamp":1732590630,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","399300","301111","BK0050","BK0102","002864","BK0077","BK0201","BK0028","002349","002082","BK0188","002728","605199","BK0239","300026","600080","BK0004"],"gpt_icon":0},{"id":"2485454785","title":"红日药业11月21日现3笔大宗交易 成交金额4596.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485454785","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485454785?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:00","pubTimestamp":1732179600,"startTime":"0","endTime":"0","summary":" 11月21日,红日药业收跌0.48%,收盘价为4.12元,发生3笔大宗交易,合计成交量1384.4万股,成交金额4596.21万元。 第2笔成交价格为3.32元,成交600.00万股,成交金额1,992.00万元,溢价率为-19.42%,买方营业部为山西证券股份有限公司太原平阳路证券营业部,卖方营业部为国都证券股份有限公司天津永安道证券营业部。 进一步统计,近3个月内该股累计发生5笔大宗交易,合计成交金额为6784.02万元。该股近5个交易日累计下跌1.20%,主力资金合计净流出5655.75万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-21/doc-incwvith6849261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0077","300026","BK0188"],"gpt_icon":0},{"id":"2485451060","title":"11月21日红日药业现3笔折价19.42%的大宗交易 合计成交4596.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485451060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485451060?lang=zh_cn&edition=full","pubTime":"2024-11-21 16:45","pubTimestamp":1732178711,"startTime":"0","endTime":"0","summary":"证券之星消息,11月21日红日药业发生大宗交易,交易数据如下:近三个月该股共发生5笔大宗交易,合计成交20.6万手,折价成交5笔。该股近期无解禁股上市。截至2024年11月21日收盘,红日药业(300026)报收于4.12元,下跌0.48%,换手率1.95%,成交量52.45万手,成交额2.15亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100025942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300026","BK0188"],"gpt_icon":0},{"id":"2478608688","title":"10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478608688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478608688?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:51","pubTimestamp":1729846265,"startTime":"0","endTime":"0","summary":"证券之星消息,10月25日红日药业发生大宗交易,交易数据如下:近三个月该股共发生7笔大宗交易,合计成交16.07万手,折价成交7笔。该股近期无解禁股上市。截至2024年10月25日收盘,红日药业(300026)报收于4.05元,上涨0.25%,换手率2.78%,成交量74.74万手,成交额3.01亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500027708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","300026"],"gpt_icon":0},{"id":"2477768679","title":"红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477768679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477768679?lang=zh_cn&edition=full","pubTime":"2024-10-24 19:22","pubTimestamp":1729768921,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)发布2024年第三季度报告,公司前三季度营业收入44.41亿元,同比下降9.78%;归属于上市公司股东的净利润1.68亿元,同比下降66.94%;归属于上市公司股东的扣除非经常性损益的净利润1.58亿元,同比下降64.12%;基本每股收益0.06元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300026"],"gpt_icon":0},{"id":"2477505517","title":"红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477505517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477505517?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:05","pubTimestamp":1729760734,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业披露,截至2024年9月30日公司股东户数为11.08万户,较6月30日减少849.0户,减幅为0.76%。在中药行业个股中,红日药业股东户数高于行业平均水平,截至9月30日,中药行业平均股东户数为4.94万户。从股价来看,2024年6月30日至2024年9月30日,红日药业区间涨幅为33.44%,在此期间股东户数减少849.0户,减幅为0.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400028241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300026","BK0239","BK0188"],"gpt_icon":0},{"id":"2473446124","title":"10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473446124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473446124?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:35","pubTimestamp":1728380109,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日红日药业涨9.58%创60日新高,收盘报4.46元,换手率8.84%,成交量237.35万手,成交额10.68亿元。重仓红日药业的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800026326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2466246482","title":"红日药业:目前公司与您提到的公司暂无合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2466246482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466246482?lang=zh_cn&edition=full","pubTime":"2024-09-12 18:03","pubTimestamp":1726135435,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业09月12日在投资者关系平台上答复投资者关心的问题。收到时间均为2024年9月6号。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200029975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300026","BK0188"],"gpt_icon":0},{"id":"2466452177","title":"红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2466452177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466452177?lang=zh_cn&edition=full","pubTime":"2024-09-10 23:00","pubTimestamp":1725980438,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业09月10日在投资者关系平台上答复投资者关心的问题。公司有没有治疗登革热病毒的药物,请回答红日药业董秘:您好,公司产品血必净注射液被纳入登革热诊疗方案推荐用药,谢谢关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000037999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","300026"],"gpt_icon":0},{"id":"2466115651","title":"红日药业新注册《网采对接管理平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2466115651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466115651?lang=zh_cn&edition=full","pubTime":"2024-09-10 01:25","pubTimestamp":1725902729,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业(300026)新注册了《网采对接管理平台V1.0》项目的软件著作权。今年以来红日药业新注册软件著作权5个,较去年同期增加了25%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了9369.01万元,同比减7.41%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000001627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","300026"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"天津市武清区新技术产业园区武清开发区泉发路西","stockEarnings":[{"period":"1week","weight":-0.0591},{"period":"1month","weight":0.0153},{"period":"3month","weight":0.2171},{"period":"6month","weight":0.2595},{"period":"1year","weight":-0.0423},{"period":"ytd","weight":-0.0537}],"companyName":"天津红日药业股份有限公司","boardCode":"AI0027","perCapita":"24235股","boardName":"医药制造业","registeredCapital":"300415万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。","serverTime":1735051440016,"listedPrice":60,"stockholders":"110822人(较上一季度减少0.76%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"红日药业,300026,红日药业股票,红日药业股票老虎,红日药业股票老虎国际,红日药业行情,红日药业股票行情,红日药业股价,红日药业股市,红日药业股票价格,红日药业股票交易,红日药业股票购买,红日药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}